Wall Street Braces for Shutdown: Stocks Rally as Fed Cuts Loom – Tech & Defense in Focus

Wall Street Braces for Shutdown: Stocks Rally as Fed Cuts Loom – Tech & Defense in Focus

  • U.S. stock futures climbed modestly Monday, with S&P 500 futures up ~0.3%, as traders braced for a looming government shutdown Reuters.
  • All three major indexes were near record highs entering the week; the S&P 500 is up ~14% YTD after Friday’s close Reuters. Investors are betting on further Fed rate cuts (futures imply ~40–50 bps more by Dec) despite resilient economic data Reuters.
  • Attention turned to Congress: without a funding deal by Tuesday midnight, a shutdown could begin Wednesday, delaying jobs and economic reports Reuters Reuters. President Trump met Congressional leaders Monday in a last-ditch bid to avoid a shutdown. Meanwhile, the Fed is expected to keep policy on hold next week but is likely to cut again later this year.
  • Gold hit a record high (∼$3,808/oz) as cautious investors bought safety, while oil prices eased near $70/barrel on reports of an OPEC+ production increase Reuters.   Image: A trading-screen display on the NYSE floor, Sept 2025. Markets were calm as investors awaited key data and policy news Reuters Reuters.
  • Company News: Stellantis (NYSE: STLA) appointed Joao Laranjo as new CFO, taking over duties on Sept. 29 Globenewswire. AstraZeneca (NYSE: AZN) announced it will list its ordinary shares directly on the NYSE, lifting its stock ~1.3% Reuters. U.S. auto parts supplier First Brands Group filed for Chapter 11 protection Monday; lenders including Jefferies (NYSE: JEF) are heavily exposed to its debt Reuters.
  • Sector Highlights: Drugmakers and healthcare saw moves – GSK (LSE: GSK) surged 3.3% after its CEO announced a January exit, and AZN’s listing news boosted pharma sentiment Reuters. Defense and industrial stocks rose on fiscal stimulus hopes, in line with analysts’ notes that asset managers are shifting from pure AI bets into infrastructure, energy and defense Reuters. Conversely, U.S. medtech shares had fallen late last week after a Commerce Dept. probe on medical-device imports Reuters.
  • Macro & Fed Outlook: Economic indicators remained mixed. August U.S. job growth came in weak, yet core inflation is still sticky, prompting Fed officials to call policy “challenging” Reuters. Traders trimmed some of their aggressive Fed-cut bets as the economy shows resilience. Fed speakers this week (NY Fed’s Williams, others) and Friday’s jobs report loom large. A successful funding bill or shutdown resolution could ease volatility, while a shutdown might temporarily delay data releases (e.g. payrolls) Reuters.
  • Analyst Commentary: With stocks near all-time highs, several strategists urge caution. “I do get a little bit more nervous…any kind of unexpected hiccup could cause a near-term dislocation,” says Ameriprise strategist Anthony Saglimbene Reuters. UBS CIO Mark Haefele notes investors have “underestimated” the impact of massive fiscal stimulus, and are now re-allocating into sectors like infrastructure, power and healthcare Reuters. Generali’s Antonio Cavarero adds that “fiscal stimulus is always a big element” in market performance Reuters. These voices highlight that after a steep rally, stocks may need fresh catalysts amid uncertainties.
  • Next Steps: U.S. markets will watch the outcome of Monday’s funding talks, speeches by Fed officials, and the government’s fiscal health. Tuesday’s pre-market action may hinge on any overnight developments (e.g. Asian data or a shutdown update). Analysts note that historically the fourth quarter has been bullish (Nasdaq +6% on average), but stress that geopolitical and policy risks (tariffs on trucks/pharma take effect Wed Reuters, elections coming) could spark swings.

Sources: Reuters, CNBC, Bloomberg, company filings Reuters Globenewswire Reuters Reuters Reuters Reuters Reuters.

Stock Market Today

  • RS Group RS1 story nudges fair value higher after analyst updates
    January 11, 2026, 4:05 PM EST. RS Group's story shifts modestly as analysts refresh assumptions. The central fair value anchor rose to £7.16 from £6.98, with revenue growth forecast up to 5.02% from 3.57% and the discount rate nudging to 8.67% from 8.57%. Analysts describe a balance between improving execution and sector risk. Morgan Stanley upgraded RS Group to Overweight from Equal Weight, with a price target of 790p. Rothschild & Co Redburn's William Blunt lifted the rating to Buy and raised the target to 760p from 560p. Bearish notes point to a prior target trim and ongoing headwinds in staffing and chemical distribution. RS Group also declared an interim dividend of 8.7p for the six months ended 30 September 2025, payable 2 January 2026. Separately, RS Group expanded its MEAN WELL range with XDR-E and XTR DIN rail units.
Spectacular Space News Blitz: SpaceX Soars 28 Satellites, NASA Unleashes Solar Probes, China’s New Weather Satellite & More (Sept 28–29, 2025)
Previous Story

Spectacular Space News Blitz: SpaceX Soars 28 Satellites, NASA Unleashes Solar Probes, China’s New Weather Satellite & More (Sept 28–29, 2025)

AI Stocks Frenzy: Nvidia’s $100B Bet & Other Big Moves Ignite Markets (Sept 28–29, 2025)
Next Story

AI Stocks Frenzy: Nvidia’s $100B Bet & Other Big Moves Ignite Markets (Sept 28–29, 2025)

Go toTop